Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects [Phase 3]
Phase III trial evaluating the efficacy and safety of MC2-01 cream compared with CAL/BDP gel and vehicle in plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-28Clinical Trial Update: A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis [Phase 3]
A Phase 3 pediatric trial evaluating apremilast in children with mild to moderate plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 bioequivalence study comparing two treatments for plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]
Phase 2 trial results for LY4100511 (DC-853) in adults with moderate-to-severe plaque psoriasis have been completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-08-07Clinical Trial Results: Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216) [Phase 2]
Phase 2 trial results for ARQ-151 in children with plaque psoriasis (plaque psoriasis) evaluating maximal usage pharmacokinetics and safety;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-04Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating pharmacokinetics, safety, and effectiveness of certolizumab pegol in children with chronic plaque psoriasis is comp…
-
EMA approval · 2026-07-24First oral medicine targeting interleukin-23 receptor recommended for plaque psoriasis
The EMA recommends the first oral medicine that targets the interleukin-23 receptor for plaque psoriasis, showing potential to clear skin le…
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis [Phase 2]
Phase 2 trial results for TLL018 in moderate-to-severe plaque psoriasis, reporting efficacy and safety data.
-
CLINICAL_TRIALS trial_result · 2026-07-15Clinical Trial Update: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating apremilast for safety and efficacy in Japanese children with moderate to severe plaque psoriasis; status indicates …
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis [Phase 3]
Phase 3 study assessing guselkumab in skin of color participants with moderate-to-severe plaque and/or scalp psoriasis has completed with re…
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy [Phase 2]
Phase 2 clinical trial examining skin transcriptional profiles in chronic plaque psoriasis patients treated with adalimumab biotherapy.
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: Guselkumab Immunogenetics [Phase 4]
Phase 4 clinical trial results for guselkumab in psoriasis conditions have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 clinical trial evaluating pharmacokinetics, safety, and effectiveness of certolizumab pegol in children with chronic plaque psoriasi…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients [Phase 4]
Phase 4 trial evaluating topical skincare products for efficacy and tolerability in plaque psoriasis and psoriasis patients; results posted …
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 trial evaluates the efficacy and safety of JNJ-77242113 versus placebo and ustekinumab in moderate to severe plaque psoriasis; sta…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 clinical trial update for TAK-279 in adults with moderate-to-severe plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight [Phase 4]
Phase 4 clinical trial comparing an adjusted brodalumab dose with the standard dose in adults with moderate-to-severe plaque psoriasis and b…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial is evaluating the effect of Bimekizumab on gene expression biomarkers in adults with moderate to severe plaque psor…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis. [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of D-2570 for moderate to severe plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the pharmacokinetics, safety, and effectiveness of certolizumab pegol (Cimzi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis [Phase 2]
A Phase 2 dose-ranging trial evaluating ORKA-002 in adults with moderate-to-severe plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis. [Phase 1]
A Phase 1 study comparing Tapinarof Cream 1% and Vtama Cream 1% in the treatment of plaque psoriasis has completed, evaluating safety and pr…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis [NA]
Clinical trial update for PROXERA PSOMED 20 and PROXERA PSOMED 40 devices evaluating treatment of plaque psoriasis and non-pustular palmopla…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis [Phase 2]
Open-label extension study update for ORKA-001 in plaque psoriasis (Phase 2), currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis. [Phase 3]
A Phase III multicenter, randomized, double-blind, placebo-controlled trial will evaluate the efficacy and safety of RSS0393 ointment in adu…